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ABSTRACT
Osler-Weber-Rendu syndrome (OWRS) is a rare hereditary, autosomal dominant disease 
characterized by a local angiodysplasia. Its clinical characteristics are vascular hamarto-
 mas of the skin and oral mucosa, arteriovenous malformations in the lungs, liver, kidney 
and brain, and episodes of epistaxis. The oral lesions, which become apparent through  
hemorrhagic telangiectasia, may be the first sign of the disease. This is a case report of 
a 74-year-old woman whose diagnosis of OWRS was established by her dentist based 
on the presence of telangiectasia in the skin and oral mucosa, reports of frequent nose-
bleeds of unknown etiology and a family history of telangiectasia. Amputation of a 
lower limb and comorbidities, such as cardiopathy, nephropathy and rheumatic disor-
ders, completed the profile. OWRS causes major vascular changes that can be diagnosed 
initially by a dentist. In this article, we describe the skills and knowledge that dentists 
need to monitor patients with OWRS properly.
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Hereditary hemorrhagic telangiectasia, or Osler-Weber-Rendu syndrome (OWRS), was first described by Sutton in 1864 
and Babington in 1865 as a hereditary epi-
staxis disease.1,2 In 1896, Rendu described 
the disease as a pseudo hemophilia related to 
hereditary epistaxis. In 1901, Osler described 
the clinical symptoms of the syndrome and 
emphasized its hereditary occurrence. Weber 
(1907) recognized OWRS as a clinical entity 
distinct from hereditary hemophilia, and 
Hanes (1909) named the syndrome hereditary 
hemorrhagic telangiectasia.
OWRS is an uncommon autosomal dom-
inant disorder characterized by an angiodys-
plasia in the presence of telangiectasias of 
the skin and oral mucosa and arteriovenous 
malformations in the brain, lung, liver and 
gastrointestinal tract.3 Its incidence is 1 in 
5,000–10,000 in the general population.4 
Bleeding episodes may occur due to capil-
lary fragility rather than disturbances in 
coagulation.1,5
OWRS manifests itself in 2 forms: heredi-
tary hemorrhagic telangiectasia type 1 (HHT1) 
where there is mutation of the endoglin gene 
on chromosome 9 with pulmonary involve-
ment; and type 2 (HHT2) with a mutation 
in the activin receptor-like kinase-1 (ALK-1) 
gene. HHT2 is the milder form and its onset 
is later. The proteins produced by the involved 
genes may play an important role in the integ-
rity of the vessel wall.6
The clinical characteristics of OWRS are 
epistaxis, telangiectasias of the skin and oral 
mucosa, visceral lesions (lungs, gastrointes-
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Figure	1: Telangiectasias on the face. Figure	2:	Telangiectasias on the 
tongue.
tinal tract, liver and brain) and family history.7,8 The 
differential diagnosis of OWRS includes benign liver 
disease, benign hereditary telangiectasia, CREST (cal-
cinosis, Raynaud phenomenon, esophageal dysmo-
tility, sclerodactyly and telangiectasia) syndrome and 
ataxia-telangiectasia.8 
Dentists can play an important role in the diagnosis 
of OWRS, as its first signs often appear in the oral mu-
cosa. Moreover, the management of a patient with OWRS 
must be suited to his or her systemic profile to ensure safe 
and efficient dental treatment.
Case	Report
A 74-year-old woman was referred to the special 
care dentistry centre of our dental school for treat-
ment. The patient’s medical history included congestive 
heart failure, chronic renal failure, hypertension, hypo-
thyroidism and rheumatism. Her right lower limb had 
been surgically amputated because of vascular disorders. 
She reported frequent nosebleeds and a family history of 
telangiectasias and epistaxis.
Laboratory tests showed significant changes in her red 
blood cell count—hypochromic anemia with anisocytosis 
and a high level of liver enzymes, with no changes in co-
agulation (Table 1).
During the extraoral and intraoral 
clinical examination, telangiectasias were 
found on the skin, especially on the face 
(Fig. 1) and upper limbs, and were highly 
visible on the oral mucosa in the regions 
of the tongue (Fig. 2), hard palate and 
in the vermilion of the lip. Also present 
were periodontal disease and caries. 
Panoramic and periapical radiographs 
were taken to develop a dental treatment 
plan.
The patient’s signs and symptoms 
pointed toward a working diagnosis of 
hereditary hemorrhagic telangiectasia 
or OWRS. The patient was referred to an 
internal medicine specialist who con-
firmed our diagnosis and began medical 
monitoring for possible systemic changes 
resulting from the syndrome. Before 
dental treatment, antibiotic prophylaxis 
(500 mg amoxicillin) was administered 
every 8 hours, starting 12 hours before 
the procedure and continuing for 7 days 
after, to avoid the risk of cerebral ab-
scesses or pulmonary infections due to 
the arteriovenous malformations found 
in OWRS patients.9 Other special meas-
ures taken during treatment were use of a 
vertical dental chair position to reduce 
the risk of lung and nasal bleeding, measurement of 
blood pressure before and after the procedure, request for 
an up-to-date laboratory evaluation and assessment of 
her clinical condition at the time of treatment, because of 
the potential for renal failure and liver disease.
Discussion
A final diagnosis of OWRS is based on clinical cri-
teria,10 usually the Curaçao criteria: telangiectasia on 
the face, hands and oral cavity; recurrent epistaxis; ar-
teriovenous malformations with visceral involvement; 
and family history. Diagnosis is confirmed in the pres-
ence of at least 3 of these manifestations.11 In our case, 
the clinical signs of telangiectasias of the skin, espe-
cially in the face, upper limbs and on the oral mucosa, 
combined with reported nosebleeds and a family history 
of telangiectasia and epistaxis were important factors 
leading us to suspect OWRS.
Mucocutaneous telangiectasias occur in about 90% 
of cases of OWRS.8,12 Histologically, they appear as a 
superficial collection of dilated blood vessels with a 
layer of endothelial cells in the lamina propria. Electron 
microscope studies show a lack of perivascular elastic 
fibres and smooth muscle.1
Once the diagnosis is established, complementary 
imaging tests, such as computed tomography ultrasound 
Table	1	Results of blood tests
Test Patient’s	results Reference	value
INR 1 0.7–1.2
aPTT (s) 33 s 30–45 s
PT (s) 13 s 11–14.6 s
BT (min) 2.17 1–4
Platelet count (no./mm3) 280,000 165,000–397,000
Erythrocyte count (cells/mm3) 3.97 4.3–5.9
Hemoglobin (g/dL) 10.9 12–16
aPTT = partial thromboplastin time, BT = bleeding time, INR = international normalized ratio, 
PT = prothrombin time.
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and magnetic resonance imaging, are important to detect 
whether there is any involvement of organs, such as lungs, 
liver, kidneys and the brain.10 Pulmonary arteriovenous 
malformations occur in more than a third of patients 
with the disease and can cause various complications, 
such as hypoxia, pulmonary hemorrhage and cerebral 
embolism.9 Dental professionals must be aware of these 
complications, keep the dental chair in a vertical position 
during dental treatment and be prepared to administer 
oxygen.
Vascular lesions in the brain predispose patients to 
cerebral abscesses,9 a situation that requires special care 
during invasive dental procedures, such as antibiotic pro-
phylaxis, especially in infected areas. An OWRS patient’s 
risk of developing a brain abscess ranges from 5% to 
9%. Few cases of cerebral abscess due to bacteremia of 
odontogenic origin have been described so far. Most or-
ganisms isolated from brain abscess aspirates have been 
microaerophilic and anaerobic bacteria commonly and 
often specifically isolated in periodontal infections.13 
Rivero-Garvia14 reported the case of a 41-year-old 
patient with OWRS who had teeth extracted without 
antibiotic prophylaxis and, after a few days, developed 
a brain abscess. This finding confirms the import-
ance of careful dental care in this group of patients. 
Arteriovenous fistulae in the lungs and vascular malfor-
mations are important in the pathogenesis of cerebral 
abscess. A peripheral septic microembolism can reach the 
brain and cause a brain abscess. Approximately 10% of 
patients with arteriovenous fistulae in the lungs develop 
cerebral abscess.15,16 
There is no evidence in the scientific literature of the 
need to use antibiotic prophylaxis in invasive dental pro-
cedures that may cause bacteremia in patients with ar-
teriovenous malformations, who have a higher likelihood 
of developing cerebral abscesses.2 However, the rarity of 
the disease and lack of prospective studies addressing the 
risk of brain abscesses through oral manipulation makes 
the use of antibiotic prophylaxis empirical in this case.
Although for normal patients there is little risk of 
exacerbation of anemia due to dental treatment, pa-
tients with OWRS with severe anemia (hemoglobin level 
<10 mg/dL) should avoid certain routine procedures, as 
invasive procedures can exacerbate anemia, depending 
on the amount of blood that is lost.17,18
The medical treatment of OWRS is only palliative and 
depends on the severity and stage of disease. Symptoms 
of OWRS increase with age. Some measures, including 
iron supplements, blood transfusions and laser therapy, 
have met with varying degrees of success; sclerosing tech-
niques have been used to control epistaxis. In patients 
with recurrent episodes of epistaxis, surgery of the nasal 
septum may be indicated.12
 A study in Italy19 reported excellent hemostatic re-
sults using Nd-Yag laser treatment in 8 patients with 
OWRS for the control of epistaxis and oral bleeding. This 
treatment was well accepted by patients and costs were 
low. However, researchers are divided on the efficiency 
of the use of lasers with OWRS patients, and there is no 
specific protocol for their use.
The prognosis associated with OWRS is good, but 
the morbidity is significant.20 Moreover, a mortality rate 
of 1%–2% is reported due to complications related to 
epistaxis, and it rises to 10% in patients with cerebral 
abscess.6
OWRS causes major vascular changes that may be 
initially diagnosed by the dentist. Skill and knowledge 
of the disease are required for proper dental monitoring 
of patients with OWRS. a
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